EHC Encompass Health Corp
Services-Hospitals · NYSE · SEC CIK 785161 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY19.1%
TTM EPS YoY21.0%
Revenue 3-yr CAGR10.5%
Net income 3-yr CAGR22.1%
Margins
Gross margin—
Operating margin—
Net margin10.2%
FCF margin7.2%
EBITDA margin—
Returns
ROE25.5%
ROA8.9%
ROIC (approx.)—
Asset turnover0.88x
Leverage & solvency
Liabilities / assets52.9%
Debt / equity0.97x
Current ratio1.09x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.02x
Accruals ratio-9.1%
Payout ratio11.9%
Capex / revenue13.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B |
| SG&A expense | $236.20M | $209.20M | $201.70M | $154.30M | $169.50M |
| Operating income | — | — | — | $539.50M | $559.60M |
| Interest expense | $123.20M | $137.40M | $143.50M | $175.70M | $164.30M |
| Pretax income | $953.00M | $749.60M | $607.20M | $450.80M | $505.00M |
| Income tax | $192.90M | $150.20M | $132.20M | $100.10M | $101.90M |
| Net income | $566.20M | $455.70M | $352.00M | $271.00M | $412.20M |
| EBITDA | — | — | — | $783.10M | $779.20M |
| EPS (basic) | 5.62 | 4.53 | 3.51 | 2.72 | 4.15 |
| EPS (diluted) | 5.54 | 4.46 | 3.47 | 2.70 | 4.11 |
| Dividends declared per share | 0.72 | 0.64 | 0.60 | 0.86 | 1.12 |
| Weighted avg. shares (diluted) | 102.20M | 102.20M | 101.30M | 100.40M | 100.20M |
| Balance sheet | |||||
| Cash & equivalents | $72.20M | $85.40M | $69.10M | $21.80M | $49.40M |
| Receivables | $619.20M | $593.00M | $599.80M | $524.80M | $502.10M |
| Current assets | $905.90M | $886.90M | $841.80M | $717.20M | $921.40M |
| PP&E, net | $4.10B | $3.64B | $3.30B | $2.94B | $2.58B |
| Goodwill | $1.32B | $1.28B | $1.28B | $1.26B | $1.24B |
| Intangibles | $308.30M | $297.80M | $278.20M | $282.30M | $158.40M |
| Total assets | $7.09B | $6.53B | $6.10B | $5.64B | $6.86B |
| Current liabilities | $836.40M | $841.00M | $656.40M | $575.90M | $748.80M |
| Short-term debt | $43.60M | $138.60M | $24.80M | $25.20M | $37.80M |
| Long-term debt | $2.45B | $2.36B | $2.69B | $2.74B | $3.24B |
| Total debt | $2.49B | $2.50B | $2.71B | $2.77B | $3.28B |
| Total liabilities | $3.81B | $3.69B | $3.81B | $3.77B | $4.47B |
| Shareholders' equity | $2.44B | $2.07B | $1.65B | $1.31B | $1.91B |
| Net debt | $2.42B | $2.41B | $2.64B | $2.75B | $3.23B |
| Cash flow statement | |||||
| Operating cash flow | $1.18B | $1.00B | $850.80M | $705.80M | $715.80M |
| Capital expenditure | $736.40M | $642.50M | $583.10M | $584.10M | $545.70M |
| Free cash flow | $439.20M | $360.30M | $267.70M | $121.70M | $170.10M |
| Investing cash flow | -$764.60M | -$653.30M | -$602.80M | -$627.00M | -$666.30M |
| Financing cash flow | -$431.20M | -$330.60M | -$197.20M | -$145.70M | -$240.10M |
| Depreciation & amortization | $327.90M | $299.60M | $273.90M | $243.60M | $219.60M |
| Stock-based compensation | $56.50M | $48.30M | $50.60M | $29.20M | $29.10M |
| Dividends paid | $71.10M | $62.80M | $60.40M | $99.00M | $112.20M |
| Share buybacks | $158.00M | $31.10M | $0 | $0 | $0 |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.